7 Things for Spine Surgeons to Know for Thursday

Heather Linder -   Print  |

Here are seven things for spine surgeons to know for Thursday, Nov. 14, 2013.DMP Spine Biologics to distribute Bacterin bone graft products in Europe.
Bacterin International Holdings developed an alliance with DMP Spine Biologics to distribute Bacterin's bone graft products in European markets.

Patient fear of moving after spine surgery could affect outcomes.
Fear of movement after spine surgery could have a negative impact on the patient's pain, disability and physical health six months postoperatively. Researchers found early postoperative fear of movement and depression at six weeks predicted pain intensity, pain interference, disability and physical health at six months after surgery.

Lawnwood Regional Medical Center purchased Mazor Robotics' Renaissance spine system.
Lawnwood Regional Medical Center & Heart Institute in Ft. Pierce, Fla., purchased a Renaissance system from Mazor Robotics for complex spine surgeries and treatments of disorders deep within the brain.

Instrumentation for lumbar spondylolisthesis surgery brings higher costs.
Spine surgeons and researchers recently published an article in The Journal of Bone and Joint Surgery comparing complications, reoperation rates and costs for patients undergoing surgery for lumbar spondylolisthesis who received either decompression, decompression with instrumented arthrodesis or decompression with non-instrumented arthrodesis. Complication rates were similar, but decompression alone showed higher reoperation rates. Instrumentation was associated with higher costs.

Alphatec Spine lost $14.5M in Q3 after PurGen device discontinuation.
Alphatec Spine reported a $14.5 million loss in the third quarter, a 487 percent increase from the $2.5 million loss during the same period last year, which corresponds with the company's decision to discontinue the PurGen Osteoprogenitor Cell Allograft from its product portfolio after a significant investment in clinical trials.

Titan Spine celebrated 18k implantations of interbody fusion device.
Mequon, Wis.-based Titan Spine reached an 18,000 implantation milestone for its Endoskeleton interbody fusion device.

Dysphagia higher than baseline levels for artificial disc replacement & ACDF at four weeks.
Physician researchers conducted a prospective randomized controlled study to determine and explain differences in dysphagia between patients undergoing artificial disc replacement and anterior cervical decompression and fusion. They found dysphagia was significantly higher than baseline levels in both groups at four weeks. There was also a stronger association to implant type than to number of surgical levels for dysphagia.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers